Chronic inflammatory bowel diseases (IBD), including crohn’s disease and ulcerative colitis, are rapidly spreading beyond Western countries to Asia, Latin America, and Africa. A recent international study in “Nature” magazine presents a global model identifying potential triggers for this rise.

Crohn’s disease and ulcerative colitis involve excessive production of inflammation-promoting substances in the intestinal wall.Crohn’s disease can affect the entire digestive tract, while ulcerative colitis is limited to the large intestine and rectum.

understanding the Symptoms of IBD

Frequent stool urges, incontinence, flatulence, and diarrhea are typical symptoms of IBD. In Germany, approximately 650,000 people experience these symptoms, with an estimated 6 to 8 million affected worldwide. The global spread follows a pattern divided into four phases:

• Emergence: Isolated cases, often in countries with limited infrastructure and diagnostics.
• Acceleration: A rapid increase in new cases. The Faröer Islands reported a high incidence of 73.7 new cases per 100,000 inhabitants in 2011.
• Compounding Prevalence: The incidence stabilizes, but the total number of patients continues to rise due to the young age of those affected and the long duration of the disease.
• Prevalence Equilibrium: A hypothetical stage where the total number of patients reaches a stable level. Canada, Denmark, and Scotland are projected to reach this point by 2040.

Lifestyle Factors and Potential Triggers

The causes of IBD are complex, involving genetic predisposition and the immune system. Psychological stress, such as stress, fear, and depression, can also negatively impact the disease course. However, the Western lifestyle is a central focus of many current hypotheses.

Suspected risk factors include:

• Processed foods with additives (e.g., emulsifiers)
• Sugar-rich diet with low fiber content
• Microplastics in food
• Lack of exercise and antibiotic use

interestingly, the number of cases is increasing even in countries like India, where vegetarianism is common, suggesting that industrial food processing and environmental factors also play a role.

The Silent Crisis in Developing Countries

Newly industrialized regions face a growing number of young patients with frequently enough inadequate medical infrastructure. A lack of colonoscopies, specialists, and medication leads to late diagnoses and unequal care opportunities.

Africa and parts of South Asia may be on the verge of a significant increase in cases. Limited data hinders precise classification, but increasing urbanization and industrialization pose a threat of transitioning to the second phase of the disease’s spread.

IBD in Germany: A Growing common Disease

In germany,Crohn’s disease and ulcerative colitis are considered common diseases,with increasing incidence,especially among young adults. The German Society for gastroenterology (DGVS) emphasizes the serious effects on the quality of life for those affected, including symptoms like diarrhea, abdominal pain, and weight loss, as well as the associated shame.

The DGVS highlights the importance of education,early diagnosis,and preventive lifestyle measures to manage chronic inflammatory bowel diseases (IBD). While ibds like Crohn’s disease or ulcerative colitis are often recurring and incurable, they can be treated to improve quality of life.

Open interaction with friends, family, or partners can reduce inhibitions and promote understanding. Relaxation techniques like meditation, progressive muscle relaxation, or breathing exercises can help manage stress, a common trigger. Support groups, such as the German Crohn’s Disease/Ulcerative colitis Association, offer valuable connections. Knowing the location of “safe places,” such as restrooms identified by apps like “Toilet Finder,” can also provide reassurance.

Prevention: Hope for the Future

Research is focusing on identifying early risk markers in the microbiome or genetics. Preventive strategies, similar to those for type 1 diabetes or rheumatism, could play a crucial role in the future.

Researchers hope that one day, they can delay or prevent the onset of the disease through approaches like microbiome modification, early medication, or lifestyle interventions.